Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Immunology/Infectious Diseases | Pulmonary/Respiratory Diseases | Pediatrics/Neonatology

Influenza

Alabama

Birmingham : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Arkansas

Little Rock : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

California

Paramount : Center for Clinical Trials, LLC

¿Piensa Que Tiene Una GRIPE? Entonces Mire Esto.

Paramount : Center for Clinical Trials, LLC

IS it looking like the FLU? THEN READ THIS.

Paramount : Center for Clinical Trials, LLC

IS it looking like the FLU? THEN READ THIS.

Colorado

Denver : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Connecticut

New London : Coastal Connecticut Research, LLC

Are your cold or flu-like symptoms making you miserable?

New London : Coastal Connecticut Research, LLC

WE ARE CONDUCTING FLU TESTING AT NO COST

Delaware

Newark : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Florida

Clearwater : Tampa Bay Medical Research, Inc

Pneumonia Vaccine/Flu Vaccine Research Study

St Petersburg : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

West Palm Beach : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Illinois

Chicago : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Chicago : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Chicago : Radiant Research - Chicago

Investigational Flu Vaccine Research

Chicago : Research Site:

IRIS: An Influenza Resistance Information Study

Kansas

Lenexa : Research Site:

IRIS: An Influenza Resistance Information Study

Massachusetts

Springfield : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Michigan

Ann Arbor : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Detroit : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Detroit : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Minnesota

Brooklyn Center : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Montana

Missoula : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Nevada

Las Vegas : AB Clinical Trials

DO YOU OR SOMEONE YOU LOVE HAVE SYMPTOMS SUGGESTIVE OF THE FLU?

New Jersey

Hackensack : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

North Carolina

Charlotte : Metrolina Medical Research

FLU VACCINE: Before you get your FLU shot, consider a research study!

Salisbury : Crescent Medical Research

FLU VACCINE: Before you get your FLU shot, consider a research study!

Winston-Salem : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Winston-Salem : Piedmont Medical Research

FLU VACCINE: Before you get your FLU shot, consider a research study!

North Dakota

Fargo : Odyssey Research Services

A ParaInfluenza Virus Type III Vaccine Study

Ohio

Cincinnati : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Cleveland : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Cleveland : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Cleveland : Rapid Medical Research, Inc. (RMR)

Project 65+ Health Lives- Investigational Influenza Vaccine Exclusively for Seniors

Oklahoma

Oklahoma City : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tulsa : Vital Prospects Clinical Research Institute, P.C.

Flu got you down? You can participate in a study to examine influenza viruses for the prevalence and/or emergence of resistance to antivirals.

Pennsylvania

Philadelphia : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Philadelphia : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pittsburgh : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Pittsburgh : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tennessee

Jackson : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Nashville : Clinical Research Associates, Inc.

Flu Vaccine

Texas

Dallas : Research Across America

60 and Older Flu Vaccination

Dallas : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Dallas : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Houston : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Houston : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lubbock : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Utah

Salt Lake City : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Salt Lake City : J. Lewis Research, Inc.

Investigational A/H1N1 Flu Vaccine Study

Washington

Lakewood : Radiant Research - Tacoma

Flu Vaccine Research for Seniors

Belgium

Aalst : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Bruxelles : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Edegem : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Leuven : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Brazil

Curitiba : Research Site:

A Study on Emergence of Resistance With Tamiflu (Oseltamivir) in Patients With Seasonal Influenza

Sao Paulo : Research Site:

A Study on Emergence of Resistance With Tamiflu (Oseltamivir) in Patients With Seasonal Influenza

Bulgaria

Plovdiv : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Sofia : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Canada

Coquitlam, BC : Research Site:

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

Saskatoon, SK : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Estonia

Tallinn : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Tartu : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

France

Paris : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Toulouse : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Toulouse : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Tours : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Germany

Aachen : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Heidelberg : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Heidelberg : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

München : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Greece

Athens : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Hungary

Budapest : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Pecs : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Szeged : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Israel

Haifa : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Jerusalem : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Petach Tikva : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Petach Tikva : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Ramat Gan : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Ramat Gan : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Italy

Padova : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Pavia : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Roma : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Latvia

Riga : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lithuania

Kaunas : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Vilnius : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Poland

Bialystok : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Spain

Madrid : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Switzerland

Zuerich : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Ukraine

Kiev : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Lugnansk : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Zaporozhye : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

United Kingdom

Birmingham : Research Site:

A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.

Manchester : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.

Nottingham : Research Site:

A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.